Skip to main content
Clinical Trials/JPRN-UMIN000009265
JPRN-UMIN000009265CompletedPhase 3

The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial - The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Hiroshima University Hospital0 sites44 target enrollmentStarted: November 10, 2012Last updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
44

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1, Patients with alcoholic liver diseases. 2,Patients with viral liver diseases, autoimmune hepatitis, and primary biliary cirrhosis. 3, Paitents with pregnancy. 4, Patients who have allergy against ingredients of azithromicin. 5, Patients who have allergy against other macrolides and ketolides. 6, Patients with liver cirrhosis,liver failure including severe liver function test, hepatocellular carcinoma in the liver and other organs. 7, Patients with severe heart diseases. 8, Patients with hereditary fructose intolerance, glucose-galactose malabsorption, and sucrase-isomaltase deficiency. 9, Medical doctors decided the patients inappropriate.

Investigators

Similar Trials